| HOME >> MEDICINE >> TECHNOLOGY |
960,000518,000 Loss on sale/retirement of equipment
13,000-- Loss on impairment of equipment
65,00026,000Accretion of discount on short-term investments
--(2,000)Net change in operating assets and liabilities:Accounts receivable, net
2,132,000(1,797,000)Inventories
(1,338,000)34,000Other current assets
1,000361,000Other assets
119,00079,000Accounts payable
(592,000)602,000Accrued payroll and related expenses
75,000(572,000)Deferred revenue
(604,000)(132,000)Other liabilities
(822,000)1,156,000Net cash used in operating activities
(2,092,000)(4,428,000)Cash flows from investing activities: Capital expenditures
(266,000)(470,000) Proceeds from sale of equipment
17,000(6,741,000) Maturities of investments
--15,719,000Net cash (used in)/provided by investing activities:
(249,000)8,508,000Cash flows from financing activities: Exercise of stock options
7,000-- Issuance of common stock
3,914,000-- Payments on capital lease obligations
(2,000)(4,000)Net cash provided by/(used in) financing activities
3,919,000(4,000)Net increase/(decrease) in cash and cash equivalents
1,578,0004,076,000Cash and cash equivalents at beginning of period
10,731,0006,655,000Cash and cash equivalents at end of period
$12,309,000$10,731,000
'/>"/>
| SOURCE ThermoGenesis Corp. Copyright©2010 PR Newswire. All rights reserved |